University of Miami/Sylvester Cancer Institute - Aventura, Aventura
University of Miami/Sylvester Cancer Institute - Lennar, Coral Gables
University of Miami/Sylvester Cancer Institute - Deerfield Beach, Deerfield Beach
他8件

被験者募集中第2相

12歳以上 · 全性別 · 2026/09/22更新 · NCT02693535

AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

Research Site, Miami

被験者募集中第1/2相

12歳以上 · 全性別 · 2026/09/14更新 · NCT06137144

A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas

Local Institution - 0068, Jacksonville
Moffitt Cancer Center, Tampa

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/09/14更新 · NCT06090539

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

Research Site, Tampa

被験者募集中第2相

18歳以上 · 全性別 · 2026/09/11更新 · NCT06526793

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

North Florida/ South Georgia VA Medical Center, Gainesville
Mount Sinai Comprehensive Cancer Center, Miami
Orlando Health Cancer Institute, Orlando

被験者募集中第2相

18歳以上 · 全性別 · 2026/09/11更新 · NCT06806033

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

H. Lee Moffitt Cancer Center, Tampa

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/08更新 · NCT03666000

A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.

Clinical Trial Site, Miami

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/04更新 · NCT06393738

A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Research Site, Jacksonville

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/08/28更新 · NCT07123454

A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Florida Cancer Specialists, Fort Myers
Cancer Specialists of North Florida -St Augustine, Saint Augustine
Florida Cancer Specialists East, West Palm Beach

被験者募集中第3相

18歳以上 · 全性別 · 2026/08/17更新 · NCT05254743

eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation

University of Miami, Miami

被験者募集中

18歳以上 · 全性別 · 2026/08/13更新 · NCT07469592

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Mayo Clinic, Clinical Trials Referral Office, Jacksonville

被験者募集中第1/2相

13歳〜90歳 · 全性別 · 2026/08/06更新 · NCT06533579

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Mayo Clinic Florida, Jacksonville
AdventHealth, Orlando
Moffitt Cancer Center, Tampa

被験者募集中第3相

18歳以上 · 全性別 · 2026/08/04更新 · NCT07188558

DALY II USA/ MB-CART2019.1 for DLBCL

Baptist Health Miami Cancer Institute, Miami

被験者募集中第2相

18歳以上 · 全性別 · 2026/07/13更新 · NCT04792489

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

University of Florida Shands Medical Center, Gainesville
Nemours Children's Hospital - Mayo Jacksonville, Jacksonville
University of Miami (peds), Miami
他6件

被験者募集中観察研究

全年齢 · 全性別 · 2026/07/06更新 · NCT01351545

Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases

University of Florida, Gainesville

被験者募集中第2相

6 Months – 39 Years · 全性別 · 2026/06/04更新 · NCT05800210

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Mayo Clinic, Jacksonville

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/04/16更新 · NCT03328078

Single-Arm Comprehensive Ablative Bridging Irradiation I Prior to CD19 CAR-T In High-Risk R/R LBCL

Moffitt Cancer Center, Tampa

被験者募集中第2相

18歳以上 · 全性別 · 2026/03/31更新 · NCT06104592

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Morton Plant Hospital, Clearwater
South Florida Baptist Hospital, Plant City
Saint Anthony's Hospital Cancer Care Center, St. Petersburg
他2件

被験者募集中観察研究

18歳以上 · 全性別 · 2026/03/17更新 · NCT06418204

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

Sylvester Comprehensive Cancer Center, Miami
Florida Cancer Specialists, Sarasota

被験者募集中第4相

18歳以上 · 全性別 · 2026/03/02更新 · NCT06876662

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

Cancer Specialists, LLC, Jacksonville
Sylvester Comprehensive Cancer Center, Miami
Florida Cancer Specialists, Sarasota

被験者募集中第4相

18歳以上 · 全性別 · 2026/03/02更新 · NCT06876649

Study of SGR-1505 in Mature B-Cell Neoplasms

Napa Research, Pompano Beach

被験者募集中第1相

18歳以上 · 全性別 · 2026/02/13更新 · NCT05544019

A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors

Hematology-Oncology Associates of the Treasure Coast, Port Saint Lucie

被験者募集中第1相

18歳以上 · 全性別 · 2026/02/04更新 · NCT05892718

Lifestyle Intervention of Food and Exercise for Lymphoma Survivors

University of Miami, Miami

被験者募集中

18歳以上 · 全性別 · 2026/01/30更新 · NCT05839210

CAR-T Cell Therapy, Mosunetuzumab and Polatuzumab for Treatment of Refractory/Relapsed Aggressive Non-Hodgkin's Lymphoma (NHL).

University of Miami, Miami

被験者募集中第2相

18歳〜80歳 · 全性別 · 2025/12/31更新 · NCT05260957

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

Mount Sinai Comprehensive Cancer Center, Miami Beach
Moffitt Cancer Center, Tampa

被験者募集中第1相

18歳以上 · 全性別 · 2025/12/10更新 · NCT05602363

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Jacksonville
Massive Bio SYNERGY-AI site, Miami
Massive Bio SYNERGY-AI site, Tampa

被験者募集中観察研究

全年齢 · 全性別 · 2025/10/28更新 · NCT03452774

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

Florida Cancer Specialists, Sarasota

被験者募集中第1相

18歳以上 · 全性別 · 2025/10/02更新 · NCT05780034

Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma

University of Flordia, Gainsville

被験者募集中第2相

3歳〜39歳 · 全性別 · 2025/06/13更新 · NCT05253495

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。